| 康莱特注射液治疗原发性肺癌临床报告 |
| |
| 引用本文： | 李大鹏.康莱特注射液治疗原发性肺癌临床报告[J].中医杂志,1996,37(7):411-414. |
| |
| 作者姓名： | 李大鹏 |
| |
| 作者单位： | 浙江康莱特药业有限公司 浙江省杭州市龙井路饮马桥14号 |
| |
| 摘 要： | 经242例肺癌随机分组观察,康莱特注射液在缓解癌灶、改善证候、体重、提高生存质量、免疫功能、血象等方面均有良好作用,肿瘤缓解率为20.61％,化疗组为25.23％(P>0.05)。
|
| 关 键 词： | 肺肿瘤/中医药疗法 @康莱特注射液 |
Clinical Report on Primary Lung Carcinoma Treated with Kanglaite Injection |
| |
| Li Dapeng Kanglaite Pharmaceutical Corporation Ltd.,Hangzhou,Zhejiang.Clinical Report on Primary Lung Carcinoma Treated with Kanglaite Injection[J].Journal of Traditional Chinese Medicine,1996,37(7):411-414. |
| |
| Authors: | Li Dapeng Kanglaite Pharmaceutical Corporation Ltd Hangzhou Zhejiang |
| |
| Institution: | Li Dapeng Kanglaite Pharmaceutical Corporation Ltd.,Hangzhou,Zhejiang 310013 |
| |
| Abstract: | Through 242 cases grouped randomly for observation, it was shown that Kanglaite yielded good results on the amelioration of cancer lesion, improvement of symptoms and body weight, survival quality, immunity, and blood picture, the rate of remission being 20. 61%; that of thechemotherapy group being 21. 23% (P>0. 05). |
| |
| Keywords: | Lung tumor/TCM therapy @ Kanglaite injection |
| 本文献已被 CNKI 维普 等数据库收录！ |
